Sign Up to like & get
recommendations!
0
Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000033157
Abstract: This study was designed to observe the efficacy and safety of albumin-bound paclitaxel plus nedaplatin as neoadjuvant therapy in patients with esophageal squamous cell carcinoma (ESCC). From April 2019 to Dec 2020, patients with ESCC…
read more here.
Keywords:
albumin bound;
neoadjuvant therapy;
paclitaxel combined;
combined nedaplatin ... See more keywords